Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

Compare

5.91

-0.18 (-2.96%)

At close: Oct 9, 2025, 4:00 PM EDT

6.09

+0.18 (3.05%)

Pre-market: Oct 10, 2025, 7:42 AM EDT

Recursion Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Revenue	64.6	58.84	44.58	39.84	10.18	3.96	Upgrade
Revenue Growth (YoY)	30.14%	32.00%	11.88%	291.46%	156.89%	70.85%	Upgrade
Cost of Revenue	66.86	45.24	42.59	48.28	-	-	Upgrade
Gross Profit	-2.27	13.6	1.99	-8.43	10.18	3.96	Upgrade
Selling, General & Admin	216.25	178.18	110.82	81.6	57.68	25.26	Upgrade
Research & Development	431.2	314.42	241.23	155.7	135.27	63.32	Upgrade
Total Operating Expenses	647.45	492.61	352.05	237.3	192.95	88.58	Upgrade
Operating Income	-649.72	-479	-350.06	-245.73	-182.78	-84.62	Upgrade
Total Non-Operating Income (Expense)	0.6	14.22	17.93	6.25	-3.7	-2.39	Upgrade
Pretax Income	-649.12	-464.79	-332.13	-239.48	-186.48	-87.01	Upgrade
Provision for Income Taxes	0.02	-1.13	-4.06	-	-	-	Upgrade
Net Income	-649.13	-463.66	-328.07	-239.48	-186.48	-87.01	Upgrade
Net Income to Common	-649.13	-463.66	-328.07	-239.48	-186.48	-87.01	Upgrade
Shares Outstanding (Basic)	321	274	208	176	125	22	Upgrade
Shares Outstanding (Diluted)	321	274	208	176	125	22	Upgrade
Shares Change (YoY)	55.63%	31.92%	18.41%	40.04%	475.48%	0.98%	Upgrade
EPS (Basic)	-1.84	-1.69	-1.58	-1.36	-1.49	-3.99	Upgrade
EPS (Diluted)	-1.84	-1.69	-1.58	-1.36	-1.49	-3.99	Upgrade
Free Cash Flow	-393.87	-372.87	-299.74	-120.58	-198.41	-51.23	Upgrade
Free Cash Flow Per Share	-1.23	-1.36	-1.44	-0.69	-1.58	-2.35	Upgrade
Gross Margin	-3.51%	23.12%	4.46%	-21.16%	100.00%	100.00%	Upgrade
Operating Margin	-1005.82%	-814.09%	-785.33%	-616.74%	-1795.79%	-2135.66%	Upgrade
Profit Margin	-1004.91%	-788.02%	-735.99%	-601.05%	-1832.18%	-2196.01%	Upgrade
FCF Margin	-609.75%	-633.71%	-672.43%	-302.65%	-1949.42%	-1293.03%	Upgrade
EBITDA	-586.39	-442.51	-325.66	-233.97	-174.37	-80.67	Upgrade
EBITDA Margin	-907.78%	-752.07%	-730.58%	-587.23%	-1713.20%	-2036.14%	Upgrade
EBIT	-649.72	-479	-350.06	-245.73	-182.78	-84.62	Upgrade
EBIT Margin	-1005.82%	-814.09%	-785.33%	-616.74%	-1795.79%	-2135.66%	Upgrade
Effective Tax Rate	-0.00%	0.24%	1.22%	0.00%	0.00%	0.00%	Upgrade

Updated Aug 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q